Sage Journals: Discover world-class research

Retricted access

Other

First published 2000-4

Sequential and Multiple Testing for Dose-Response Analysis

Walter Lehmacher, Meinhard Kieser, Ludwig Hothorn

Therapeutic Innovation & Regulatory Science

Free access

Review article

First published 2008-5

Lithium Treatments: Single and Multiple Daily Dosing

Dulijano Ljubicic, Marina Letica-Crepulja, Dinko Vitezic [...]

The Canadian Journal of Psychiatry

Retricted access

Review article

First published 2022-11

Extended dosing of monoclonal antibodies in multiple sclerosis

Zoé LE van Kempen, Alyssa A Toorop, Finn Sellebjerg [...]

Multiple Sclerosis Journal

Retricted access

Other

First published 1997-10

Single and Multiple Dose Pharmacokinetics of a Pharmaceutical Compound in Elderly Subjects *

H. Jang, D. Buhrman, J. Burton [...]

Therapeutic Innovation & Regulatory Science

Retricted access

Research article

First published 2024-6

Memory B cell–guided extended interval dosing of ocrelizumab in multiple sclerosis

Delania Meng, Rosaria Sacco, Giulio Disanto [...]

Multiple Sclerosis Journal

Open access

Research article

First published 2021-12

A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis

Maria Trojano, Lluís Ramió-Torrentà, Luigi ME Grimaldi [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2025-8

Comparison of adaptive seamless Phase 2/3 designs for dose selection in clinical trials with multiple endpoints

Man Jin

Clinical Trials

Open access

Research article

First published 2020-4

Safety,tolerability,and pharmacokinetics of the selective prostacyclin receptor agonist ralinepag in single and multiple dosing studies of an immediate-release oral formulation in healthy volunteers

John S. Grundy, Christopher D. King, John W. Adams [...]

Pulmonary Circulation

Retricted access

Research article

First published 2024-6

Extended interval dosing with ocrelizumab in multiple sclerosis

Frederik Novak, Hamza Mahmood Bajwa, Kamilla Østergaard [...]

Multiple Sclerosis Journal

Retricted access

Research article

First published 2024-2

Extended interval dosing of ocrelizumab in patients with multiple sclerosis is not associated with meaningful differences in disease activity

Nicole Bou Rjeily, Kathryn C Fitzgerald, Ellen M Mowry

Multiple Sclerosis Journal

Search results